VALNEVA (EPA:VLA) | WebDisclosure

PRESS RELEASE

published on 07/17/2024 at 22:00, 4 months 16 days ago

Phase 3 VALOR Lyme Disease Trial: Valneva and Pfizer Announce Primary Vaccination Series Completion
Phase 3 VALOR Lyme Disease Trial: Pfizer and Valneva announce completion of primary vaccination series with VLA15, progressing towards a Lyme disease vaccine

Valneva Lyme Disease Vaccine Pfizer VLA15 VALOR
PRESS RELEASE

published on 07/17/2024 at 22:00, 4 months 16 days ago

Essai de Phase 3 VALOR sur la maladie de Lyme : Valneva et Pfizer finalisent la vaccination primaire de tous les participants
Pfizer et Valneva finalisent la vaccination primaire de l'essai de Phase 3 VALOR contre la maladie de Lyme, avec VLA15. Suivi des participants pour mesurer l'incidence de la maladie

Valneva Maladie De Lyme Pfizer Phase 3 VALOR Vaccination Primaire
BRIEF

published on 06/05/2024 at 07:05, 5 months 28 days ago

Valneva annonce la mise à disposition de la documentation pour son Assemblée Générale Mixte et fait le point sur l'entreprise

Assemblée Générale Valneva Mise À Jour De L'entreprise Changements À La Direction
BRIEF

published on 06/05/2024 at 07:05, 5 months 28 days ago

Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update

Executive Changes Corporate Update Valneva Shareholder Meeting
PRESS RELEASE

published on 06/05/2024 at 07:00, 5 months 28 days ago

Valneva annonce la mise à disposition des documents préparatoires à son Assemblée Générale Mixte et une évolution de son équipe de direction
Valneva annonce la mise à disposition des documents préparatoires à son Assemblée Générale Mixte et une évolution de son équipe de direction

Documents Préparatoires Valneva Assemblée Générale Mixte Équipe De Direction Kendra Wergin
PRESS RELEASE

published on 06/05/2024 at 07:00, 5 months 28 days ago

Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update
Valneva announces availability of documentation for its Combined Shareholder Meeting on June 26, 2024, along with corporate update including change in General Counsel & Corporate Secretary. Kendra Wergin appointed as successor

Corporate Update Valneva General Counsel Shareholder Meeting Kendra Wergin
BRIEF

published on 05/21/2024 at 07:05, 6 months 13 days ago

Valneva appoints Dr Hanneke Schuitemaker as Scientific Director

Nomination R&D Valneva Vaccines Dr Hanneke Schuitemaker
BRIEF

published on 05/21/2024 at 07:05, 6 months 13 days ago

Valneva nomme le Dr Hanneke Schuitemaker comme Directeur Scientifique

Nomination R&D Valneva Dr Hanneke Schuitemaker Vaccins
PRESS RELEASE

published on 05/21/2024 at 07:00, 6 months 13 days ago

Valneva annonce la nomination du Dr Hanneke Schuitemaker en tant que Directeur Scientifique
Valneva annonce la nomination du Dr Hanneke Schuitemaker en tant que Directeur Scientifique, renforçant ainsi son équipe de direction. Le Dr Schuitemaker apportera son expertise en R&D pour développer des solutions vaccinales innovantes

R&D Valneva Dr Hanneke Schuitemaker Vaccins Directeur Scientifique
PRESS RELEASE

published on 04/18/2024 at 16:01, 7 months 15 days ago

Original-Research: Valneva (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research bestätigt Kaufempfehlung für Valneva SE mit Kursziel von €8,60 nach positiven Ergebnissen und Schuldenerlass. Analyse von Analyst Simon Scholes, CFA

Research Update Kaufempfehlung Valneva Simon Scholes Schuldenerlass

Published on 12/03/2024 at 18:43, 20 minutes ago

CORRECTION FROM SOURCE: MacDonald Mines Announces Letter Of Intent With Canuc Resources Corporation
Published on 12/03/2024 at 18:00, 1 hour 3 minutes ago

RE Royalties Provides $6.3 Million Financing for a 200 Megawatt Solar Project in Alberta, Canada
Published on 12/03/2024 at 17:45, 1 hour 18 minutes ago

CannapharmaRX Updates on Alberta Facility Progress and International Export Strategy
Published on 12/03/2024 at 16:36, 2 hours 27 minutes ago

Coast2Coast First Aid and Aquatics Celebrates 10 Years Anniversary with 100 Free CPR Training for Marginalized Communities
Published on 12/03/2024 at 16:00, 3 hours 3 minutes ago

Ascend Aesthetic Partners Marks First Year Uniting Top Surgeons in Aesthetic Care Nationwide

View all ACCESSWIRE

Published on 12/03/2024 at 18:45, 18 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 12/03/2024 at 18:00, 1 hour 3 minutes ago

MyHotelMatch: Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres
Published on 12/03/2024 at 18:00, 1 hour 3 minutes ago

E-PANGO: Composition du capital au 30 novembre 2024
Published on 12/03/2024 at 17:55, 1 hour 7 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/03/2024 at 17:45, 1 hour 18 minutes ago

Kudelski IoT and PUFsecurity Combine IoT Security Strengths to Meet the Challenges of Increasing Global Regulation

View all EQS

Published on 12/03/2024 at 18:00, 1 hour 3 minutes ago

Covivio - Informations relatives au nombre total de droits de vote et d’actions composant le capital social
Published on 12/03/2024 at 18:00, 1 hour 3 minutes ago

Covivio - Information on total number of voting rights and share capital
Published on 12/03/2024 at 17:48, 1 hour 15 minutes ago

Acquisition of BIO Habitat
Published on 12/03/2024 at 17:48, 1 hour 15 minutes ago

Acquisition de BIO Habitat
Published on 12/03/2024 at 17:46, 1 hour 17 minutes ago

Saint-Gobain cancels 5 million shares

View all LES ECHOS COMFI WIRE

News